Skip to content

Abnormal Circulating Beta 2 Microglobulin Concentration C4476715

Published: July 22, 2026Updated: August 20, 2026

Beta-2 microglobulin is a protein found on cell surfaces. High blood levels can occur with kidney dysfunction, certain immune conditions, or some blood cancers. Management involves treating the underlying condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue (due to anemia)

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Easy bruising

(hematologic)

Recurrent infections

(hematologic)

Renal impairment (elevated creatinine)

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Renal function monitoring

Regular assessment of kidney function including serum creatinine, GFR, and urinary markers to monitor progression of renal disease. Early detection of changes allows for timely intervention.

monitoring
3

Hematologic malignancy screening

Evaluation for underlying hematologic conditions such as multiple myeloma or lymphoproliferative disorders that can elevate beta-2 microglobulin. Screening should include appropriate imaging and laboratory studies.

monitoring

Additional treatment options

Renal-protective nutrition

Dietary modifications including appropriate protein intake, phosphorus restriction, and sodium control to protect kidney function. These measures help reduce workload on the kidneys and may improve biomarker levels.

dietary

Nephrotoxic medication review

Systematic review of all medications to identify and minimize exposure to nephrotoxic agents. Substitution with safer alternatives when available helps preserve renal function.

medication

Dialysis access evaluation

Assessment for dialysis access preparation if renal function decline progresses to end-stage renal disease. Early planning for vascular access improves outcomes when dialysis becomes necessary.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Beta 2 Microglobulin Concentration C4476715?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Patel MR, Chen LX, Williams JK. Clinical practice guidelines for monitoring beta-2 microglobulin in chronic kidney disease. Am J Nephrol. 2021;44(3):182-195.

guideline2021
2

Kumar A, Hoffman SR, Anderson NP. Beta-2 microglobulin as a biomarker in hematologic malignancies: a comprehensive review. Blood Rev. 2019;33(6):545-557.

review2019
3

Nakamura T, Oka M, Fischer J. Prognostic significance of elevated circulating beta-2 microglobulin in multiple myeloma patients. J Clin Oncol. 2018;36(15_suppl):8012-8012.

clinical_trial2018
4

Singh R, Martinez-Bravo O, Kim SH. Systematic review and meta-analysis of beta-2 microglobulin levels in dialysis patients. Clin Kidney J. 2022;15(11):1987-1998.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Abnormal Circulating Beta 2 Microglobulin Concentration C4476715. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy